首页> 美国卫生研究院文献>Molecular Pharmacology >State- and Use-Dependent Block of Muscle Nav1.4 and Neuronal Nav1.7 Voltage-Gated Na+ Channel Isoforms by Ranolazine
【2h】

State- and Use-Dependent Block of Muscle Nav1.4 and Neuronal Nav1.7 Voltage-Gated Na+ Channel Isoforms by Ranolazine

机译:Ranolazine对肌肉Nav1.4和神经元Nav1.7电压门控的Na +通道亚型的状态和使用依赖性阻滞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ranolazine is an antianginal agent that targets a number of ion channels in the heart, including cardiac voltage-gated Na+ channels. However, ranolazine block of muscle and neuronal Na+ channel isoforms has not been examined. We compared the state- and use-dependent ranolazine block of Na+ currents carried by muscle Nav1.4, cardiac Nav1.5, and neuronal Nav1.7 isoforms expressed in human embryonic kidney 293T cells. Resting and inactivated block of Na+ channels by ranolazine were generally weak, with a 50% inhibitory concentration (IC50) ≥ 60 μM. Use-dependent block of Na+ channel isoforms by ranolazine during repetitive pulses (+50 mV/10 ms at 5 Hz) was strong at 100 μM, up to 77% peak current reduction for Nav1.4, 67% for Nav1.5, and 83% for Nav1.7. In addition, we found conspicuous time-dependent block of inactivation-deficient Nav1.4, Nav1.5, and Nav1.7 Na+ currents by ranolazine with estimated IC50 values of 2.4, 6.2, and 1.7 μM, respectively. On- and off-rates of ranolazine were 8.2 μM−1 s−1 and 22 s−1, respectively, for Nav1.4 open channels and 7.1 μM−1 s−1 and 14 s−1, respectively, for Nav1.7 counterparts. A F1579K mutation at the local anesthetic receptor of inactivation-deficient Nav1.4 Na+ channels reduced the potency of ranolazine ~17-fold. We conclude that: 1) both muscle and neuronal Na+ channels are as sensitive to ranolazine block as their cardiac counterparts; 2) at its therapeutic plasma concentrations, ranolazine interacts predominantly with the open but not resting or inactivated Na+ channels; and 3) ranolazine block of open Na+ channels is via the conserved local anesthetic receptor albeit with a relatively slow on-rate.
机译:雷诺嗪是一种抗心绞痛药,可靶向心脏中的许多离子通道,包括心脏电压门控的Na + 通道。但是,尚未检查雷诺嗪对肌肉和神经元Na + 通道亚型的阻滞作用。我们比较了人类胚胎肾脏293T细胞中表达的肌肉Nav1.4,心脏Nav1.5和神经元Nav1.7亚型携带的Na + 电流的状态依赖性和使用依赖性的雷诺嗪阻滞。雷诺嗪的静息和灭活的Na + 通道阻滞作用通常较弱,抑制浓度(IC50)≥60μM时为50%。雷诺嗪在重复脉冲期间(5 Hz时+50 mV / 10 ms,在5 Hz时)对Na + 通道亚型的依赖于使用的阻断在100μM时很强,对于Nav1.4,峰值电流降低高达77%, Nav1.5为67%,Nav1.7为83%。此外,我们发现雷诺嗪对失活缺陷的Nav1.4,Nav1.5和Nav1.7 Na + 电流具有明显的时间依赖性,其估计的IC50值为2.4、6.2和1.7μM。 , 分别。 Nav1.4打开时,雷诺嗪的开通和关断速率分别为8.2μM -1 s -1 和22 s -1 Nav1.7对应通道分别为7.1μM -1 s -1 和14 s -1 。失活缺陷的Nav1.4 Na + 通道的局麻药受体处的F1579K突变使雷诺嗪的效价降低了约17倍。我们得出以下结论:1)肌肉和神经元Na + 通道对雷诺嗪阻滞的敏感性与对心脏一样。 2)在其治疗性血浆浓度下,雷诺嗪主要与开放的Na + 通道相互作用,但不与之静止或失活。 3)雷诺嗪阻断Na + 通道的开放是通过保守的局麻药受体进行的,尽管开通速度相对较慢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号